UK-China stem cell projects announced
13 Jan 2015
The Medical Research Council (MRC) and the National Natural Science Foundation of China (NSFC) have announced five co-funded awards designed to tackle knowledge gaps in stem cell research.
A total of £4 million in being provided to fund the five research projects - which forms the second phase of the UK-China Stem Cell Partnership Initiative.
The initial phase funded nine pilot awards following the successful launch of the Partnership Initiative in 2012.
“We hope these partnerships will help progress our ability to harness stem cell biology towards patient benefit
MRC director Rob Buckle
The latest round of projects will focus on basic and preclinical research that will underpin the development of novel drug and regenerative medicine based therapies for a range of disorders including heart disease, Motor Neurone Disease, Multiple Sclerosis and stroke, the MRC said.
Director of Science Programmes at the MRC Rob Buckle said: “It is gratifying to see how this initiative has developed over the past couple of years such that we are now able to launch five exciting collaborative projects that capitalise on the complementary strengths of the research teams involved from the two countries.
“We hope that these partnerships will both help progress our ability to harness stem cell biology towards patient benefit, as well as provide a foundation for further joint activity between the UK and China in stem cell research the future.”
The Stem Cell Partnership Initiative is designed to bring together a wide range of stem cell researchers, promote the exchange of scientific results and establish a platform for mutual scientific contact.
The five new research projects are as follows:
- DNA hydroxymethylation, TET enzymes and regulation of stem cell activity during skin regeneration and wound healing: University of Bradford & Shanghai Institutes for Biological Sciences
- Steroid Receptors as targets for myelin regeneration by endogenous adult neural stem cells: University of Cambridge & Second Military Medical University
- Investigating mechanistic causes of C9ORF72-related amyotrophic lateral sclerosis (ALS): University of Sheffield & Tongji University
- iPSC-derived cardiomyocytes to model estrogen receptor modulation of stress cardiomyopathy and arrhythmic syndromes: Imperial College London & Xuzhou Medical College
- Epigenetic mechanisms regulating pluripotency from embryonic to adult neurogenesis: University of Oxford & Tsinghua University